Major Breakthrough Could Help Detoxify

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

[url=] Major Breakthrough Could Help Detoxify Pollutants [/url]

141019151547-small.jpg

A major breakthrough could lead to more effective methods for detoxifying dangerous pollutants like PCBs and dioxins, scientists say. The result is a culmination of 15 years of research. It details how certain organisms manage to lower the toxicity of pollutants.

Scientists at The University of Manchester hope a major breakthrough could lead to more effective methods for detoxifying dangerous pollutants like PCBs and dioxins. The result is a culmination of 15 years of research and has been published in Nature. It details how certain organisms manage to lower the toxicity of pollutants.

The team at the Manchester Institute of Biotechnology were investigating how some natural organisms manage to lower the level of toxicity and shorten the life span of several notorious pollutants.

Professor David Leys explains the research: "We already know that some of the most toxic pollutants contain halogen atoms and that most biological systems simply don't know how to deal with these molecules. However, there are some organisms that can remove these halogen atoms using vitamin B12. Our research has identified that they use vitamin B12 in a very different way to how we currently understand it."

He continues: "Detailing how this novel process of detoxification works means that we are now in a position to look at replicating it. We hope that ultimately new ways of combating some of the world's biggest toxins can now be developed more quickly and efficiently."

It's taken Professor Leys 15 years of research to reach this breakthrough, made possible by a dedicated European Research Council (ERC) grant. The main difficulty has been in growing enough of the natural organisms to be able to study how they detoxify the pollutants. The team at the MIB were finally able to obtain key proteins through genetic modification of other, faster growing organisms. They then used X-ray crystallography to study in 3D how halogen removal is achieved.

The main drive behind this research has been to look at ways of combatting the dozens of very harmful molecules that have been released into the environment. Many have been directly expelled by pollutants or from burning household waste. As the concentration of these molecules has increased over time their presence poses more of a threat to the environment and humanity. Some measures have already been taken to limit the production of pollutants, for example PCBs were banned in the United States in the 1970s and worldwide in 2001.

Professor Leys says: "As well as combatting the toxicity and longevity of pollutants we're also confident that our findings can help to develop a better method for screening environmental or food samples."



Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

NORBIT Secures Significant NOK 120M Defence Order

Updated Category News Views 288

NORBIT Secures Significant NOK 120 Million Defence Order NORBIT has recently made an exciting announcement regarding a significant contract within its segment PIR. The company has been awarded a manufacturing order valued at NOK 120 million from a European client specializing in defence and security. This order is poised for delivery in late 2025 and early 2026, marking a...

Continue Reading
Shareholder Concerns Over BCO, SEM, NATL Transactions

Updated Category News Views 12

Is There Smoke Without Fire in Recent Company Mergers? Well, here we go again. It seems every time deals like these pop up, questions start flying about fairness and insider scoops. The big fish here? The Brink's Company (NYSE:BCO), Select Medical Holdings Corporation (NYSE:SEM), and NCR Atleos Corporation (NYSE:NATL). Halper Sadeh LLC, the investor rights firm, is on a...

Continue Reading
TG Therapeutics Director’s Recent Stock Sale Raises Questions

Updated Category News Views 120

Significant Insider Transaction at TG Therapeutics Recently, an important transaction came to light involving Yann Echelard, Director at TG Therapeutics (NASDAQ:TGTX). The details were revealed through the latest SEC filing. On a given date, Echelard sold 5,000 shares, raising a total of $162,850. Such insider trading can often prompt discussions regarding the company’s...

Continue Reading
Innovative Leadership in Facilities Management Revolutionized

Updated Category News Views 214

MasonMade Ventures Launches to Revamp Facilities Management Serial Entrepreneurs Aim to Disrupt the FM Industry through Innovative Software Solutions and Expert Trades MasonMade Ventures, established by visionary entrepreneurs Joseph Scaretta and Moses Carrasco, is set to change the face of facilities management. This operational holding company focuses on investing in...

Continue Reading
Kyverna Therapeutics Engages Investors at Upcoming Events

Updated Category News Views 136

Kyverna Therapeutics' Upcoming Investor Conferences Kyverna Therapeutics, Inc. (NASDAQ: KYTX), a pioneering clinical-stage biopharmaceutical company committed to innovative cell therapies for autoimmune diseases, is slated to present at a series of significant investor conferences this September. Warner Biddle, the Chief Executive Officer of Kyverna, will be the...

Continue Reading